Rabies Vaccine Preparation and Administration Protocol
Vaccine Characteristics
- The Centers for Disease Control and Prevention recommends that the rabies vaccine (HDCV or PCECV) must be reconstituted with the accompanying sterile diluent to a final volume of 1.0 mL in the original vial just before administration and given as an intramuscular injection in the deltoid area 1, 2
- Human Diploid Cell Vaccine (HDCV) is prepared from the Pitman-Moore strain of rabies virus grown on MRC-5 human diploid cell culture 1
- Purified Chick Embryo Cell Vaccine (PCECV) is prepared from the fixed rabies virus strain Flury LEP grown in primary cultures of chicken fibroblasts 1
- The potency of one dose is ≥2.5 international units (IU) per 1.0 mL of vaccine 1
Administration Guidelines
- The Centers for Disease Control and Prevention recommends administering a full 1.0 mL dose intramuscularly in the deltoid area for pre-exposure prophylaxis 1, 3
- For post-exposure prophylaxis in previously unvaccinated persons, the schedule is four 1.0 mL injections on days 0, 3, 7, and 14 4
- For post-exposure prophylaxis in previously vaccinated persons, the schedule is two 1.0 mL injections on days 0 and 3 3
- Rabies Immune Globulin (RIG) should be administered concurrently with the first dose of vaccine at a dose of 20 IU/kg body weight for previously unvaccinated persons 1
Important Considerations
- The vaccine should be stored according to manufacturer's recommendations 1
- Do not delay administration of post-exposure prophylaxis, as rabies is almost always fatal once clinical symptoms appear 4
- Do not mix different vaccine products during a vaccination series if possible 1
- Never administer the vaccine intradermally unless specifically using the HDCV formulation approved for this route (not currently available in the US) 5, 6
- Do not store reconstituted vaccine; use immediately after reconstitution 1, 2